| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Franchini Indrani Lall | EVP, CLO & Secretary | Feb 28, 2024 | Sale | $155.30 | 329 | 51,094 | 4,320 | Feb 29, 2024, 04:16 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Franchini Indrani Lall | EVP, CLO & Secretary | Feb 02, 2024 | Sale | $170.99 | 1,591 | 272,050 | 4,673 | Feb 05, 2024, 04:05 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Franchini Indrani Lall | EVP, CLO & Secretary | Apr 06, 2023 | Sale | $210.00 | 3,500 | 735,000 | 0 | Apr 10, 2023, 04:29 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Franchini Indrani Lall | EVP, CLO & Secretary | Feb 02, 2023 | Sale | $226.01 | 1,675 | 378,563 | 5,098 | Feb 03, 2023, 05:46 PM | |
| ALXN | ALEXION PHARMACEUTICALS, INC. | Franchini Indrani Lall | EVP, Chief Compliance Officer | Jun 08, 2021 | Option Exercise | $177.00 | 928 | 164,256 | 63,450 | Jun 09, 2021, 04:50 PM | |
| ALXN | ALEXION PHARMACEUTICALS, INC. | Franchini Indrani Lall | EVP, Chief Compliance Officer | Dec 16, 2020 | Option Exercise | $157.96 | 19,838 | 3,133,611 | 49,258 | Dec 18, 2020, 05:08 PM | |
| ALXN | ALEXION PHARMACEUTICALS, INC. | Franchini Indrani Lall | EVP, Chief Compliance Officer | Jun 08, 2020 | Sale | $114.68 | 8,256 | 946,779 | 35,071 | Jun 09, 2020, 05:05 PM | |
| ALXN | ALEXION PHARMACEUTICALS, INC. | Franchini Indrani Lall | EVP, Chief Compliance Officer | Mar 02, 2020 | Option Exercise | $90.54 | 1,267 | 114,714 | 36,474 | Mar 03, 2020, 06:16 PM | |
| ALXN | ALEXION PHARMACEUTICALS, INC. | Franchini Indrani Lall | EVP, Chief Compliance Officer | Feb 07, 2020 | Option Exercise | $102.97 | 1,406 | 144,776 | 28,221 | Feb 10, 2020, 04:57 PM | |
| ALXN | ALEXION PHARMACEUTICALS, INC. | Franchini Indrani Lall | EVP, Chief Compliance Officer | Jul 01, 2019 | Sale | $132.78 | 4,500 | 597,510 | 29,627 | Jul 02, 2019, 04:41 PM | |
| ALXN | ALEXION PHARMACEUTICALS, INC. | Franchini Indrani Lall | EVP, Chief Compliance Officer | Jun 07, 2019 | Option Exercise | $118.61 | 1,404 | 166,528 | 34,127 | Jun 11, 2019, 06:35 PM | |
| ALXN | ALEXION PHARMACEUTICALS, INC. | Franchini Indrani Lall | EVP, Chief Compliance Officer | Feb 28, 2019 | Option Exercise | $132.93 | 625 | 83,081 | 27,281 | Mar 04, 2019, 05:35 PM | |
| ALXN | ALEXION PHARMACEUTICALS, INC. | Franchini Indrani Lall | EVP, Chief Compliance Officer | Feb 07, 2019 | Option Exercise | $119.57 | 1,398 | 167,159 | 27,906 | Feb 11, 2019, 06:18 PM | |
| ALXN | ALEXION PHARMACEUTICALS, INC. | Franchini Indrani Lall | EVP, Chief Compliance Officer | Nov 28, 2018 | Sale | $118.13 | 2,605 | 307,729 | 29,304 | Nov 30, 2018, 06:15 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | Franchini Indrani Lall | EVP, Chief Compliance Officer | Jun 08, 2018 | Sale | $118.53 | 1,466 | 173,765 | 31,909 | Jun 12, 2018, 04:52 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | Franchini Indrani Lall | EVP, Chief Compliance Officer | Feb 08, 2018 | Sale | $116.31 | 1,459 | 169,696 | 25,031 | Feb 08, 2018, 07:16 PM |
Menu